Intellia Therapeutics, Inc. - NTLA

Sector: Healthcare · Industry: In Vitro & In Vivo Diagnostic Substances

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$1.636B

QoQ value delta ($000)

+$641.1M (+64.42%)

Implied price effect (QoQ)

+37.31%

Total shares

132,348,201

QoQ shares delta

+21,828,360 (+19.75%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 309 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
ARK Investment Management LLC	186,008	14,509,247	1.45%
BlackRock, Inc.	155,837	12,155,806	0.0%
VANGUARD GROUP INC	116,959	13,010,001	0.0%
STATE STREET CORP	88,748	6,922,676	0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC	79,783	6,223,325	0.0%
D. E. Shaw & Co., Inc.	73,435	5,728,177	0.04%
VANGUARD CAPITAL MANAGEMENT LLC	65,178	5,084,105	0.0%
TWO SIGMA INVESTMENTS, LP	60,329	4,705,901	0.05%
REGENERON PHARMACEUTICALS, INC.	47,472	3,702,995	99.14%
UBS Group AG	41,770	3,258,258	0.01%
GEODE CAPITAL MANAGEMENT, LLC	36,563	2,851,472	0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP	34,648	2,702,665	0.0%
DIMENSIONAL FUND ADVISORS LP	29,708	2,318,110	0.01%
MORGAN STANLEY	26,683	2,081,397	0.0%
FMR LLC	26,501	2,067,222	0.0%
Sumitomo Mitsui Trust Group, Inc.	25,294	1,973,061	0.02%
Amova Asset Management Americas, Inc.	25,274	1,973,061	0.36%
Contrarius Group Holdings Ltd	24,509	1,911,839	1.39%
JUPITER ASSET MANAGEMENT LTD	22,833	1,781,063	0.12%
TWO SIGMA ADVISERS, LP	21,093	2,346,317	0.04%
GOLDMAN SACHS GROUP INC	20,874	1,628,241	0.0%
VOLORIDGE INVESTMENT MANAGEMENT, LLC	20,659	1,611,534	0.08%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	17,912	1,397,243	0.01%
BANK OF AMERICA CORP /DE/	17,713	1,381,703	0.0%
JANE STREET GROUP, LLC	17,320	1,351,057	0.0%